CASE OF USING THE INHIBITOR OF INTERLEUKIN 1 CANACINUMAB IN PATIENTS WITH AUTO INFLAMMATORY DISEASES

S. O. Salugina; E. S. Fedorov; N. N. Kuz'mina; E. Yu. Zakharova

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

User

eng | рус

Pediatric pharmacology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Salugina S.O., Fedorov E.S., Kuz'mina N.N., Zakharova E.Yu. CASE OF USING THE INHIBITOR OF INTERLEUKIN 1 CANACINUMAB IN PATIENTS WITH AUTO INFLAMMATORY DISEASES. Pediatric pharmacology. 2015;12(2):209-217. https://doi.org/10.15690/pf.v12i2.1285

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Editor-in-Chief

Leyla S. Namazova-Baranova

Popular articles

* not an advertisement

Indexing Databases

* not an advertisement

Article Tools

Abstract

Print this article

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

S. O. Salugina
Nasonova Rheumatology Scientific Research Center, Moscow, Russian Federation
Russian Federation

E. S. Fedorov
Nasonova Rheumatology Scientific Research Center, Moscow, Russian Federation
Russian Federation

N. N. Kuz'mina
Nasonova Rheumatology Scientific Research Center, Moscow, Russian Federation
Russian Federation

E. Yu. Zakharova
Medico-Genetic Scientific Center, Moscow, Russian Federation
Russian Federation

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

For citations:

Cookies policy